1. | pacemaker1658 | |
2. | dakotamonrow | |
3. | akwench | |
4. | gnickg9585 | |
5. | forthayer |
1. | pacemaker1658 | |
2. | dakotamonrow | |
3. | akwench | |
4. | gnickg9585 | |
5. | forthayer |
1. | gnickg9585 06/13/2018 Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease |
2. | dakotamonrow 01/25/2018 Awesome News!! |
3. | pacemaker1658 02/26/2018 Receives additional FDA approval for VerzenioTM (abemaciclib), as initial treatment for advanced breast cancer |
4. | pacemaker1658 01/31/2018 Beats EPS estimates by $0.07 and beats on revenues |
5. | akwench 01/22/2018 Have to read the details of it |
6. | dakotamonrow 01/22/2018 FDA approval |
7. | pacemaker1658 05/17/2018 Lilly Data at ASCO Illustrate Patient-Driven Advances in Cancer Care |
8. | dakotamonrow 10/14/2017 I think this stock will be good through the end of the year |
9. | pacemaker1658 01/31/2018 Sees FY18 $4.81-4.91 vs $4.67 |
10. | akwench 07/24/2018 LLY closing up 5.03%. |